Precision in practice: Adopting emerging therapies for retinal diseases to reduce burden of disease

touchEXPERT FOCUS for touchOPHTHALMOLOGY

Listen to retina specialist Prof. Peter Kaiser answer a series of questions on the current clinical landscape for neovascular age-related macular degeneration and diabetic macular oedema, share his perspective on how newly available treatments are influencing the existing standard of care and provide guidance on how new therapies can be effectively integrated into clinical practice.

The expert

• Prof. Peter Kaiser, Cleveland Clinic Lerner College of Medicine, Cleveland, OH, USA

This touchPODCAST is for HCPs outside of the USA and UK only.

This activity is funded by an independent medical education grant from Bayer Consumer Care AG.

The activity is provided by touchIME.
touchIME is an EBAC® accredited provider.

For further information visit our website:
https://touchophthalmologyime.org/adopting-emerging-therapies-for-retinal-diseases